Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 2
2019 2
2020 1
2021 2
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Association analysis between symptomology and herpesvirus IgG antibody concentrations in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and multiple sclerosis.
Domingues TD, Malato J, Grabowska AD, Lee JS, Ameijeiras-Alonso J, Biecek P, Graça L, Mouriño H, Scheibenbogen C, Westermeier F, Nacul L, Cliff JM, Lacerda E, Sepúlveda N. Domingues TD, et al. Among authors: malato j. Heliyon. 2023 Jul 13;9(7):e18250. doi: 10.1016/j.heliyon.2023.e18250. eCollection 2023 Jul. Heliyon. 2023. PMID: 37519635 Free PMC article.
Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants.
Malato J, Ribeiro RM, Leite PP, Casaca P, Fernandes E, Antunes C, Fonseca VR, Gomes MC, Graca L. Malato J, et al. N Engl J Med. 2022 Sep 8;387(10):953-954. doi: 10.1056/NEJMc2209479. Epub 2022 Aug 31. N Engl J Med. 2022. PMID: 36044619 Free PMC article. No abstract available.
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors.
Sweeney CJ, Hainsworth JD, Bose R, Burris HA, Kurzrock R, Swanton C, Friedman CF, Spigel DR, Szado T, Schulze K, Price R, Malato J, Lo AA, Levy J, Wang Y, Yu W, Meric-Bernstam F. Sweeney CJ, et al. Among authors: malato j. J Clin Oncol. 2024 Jan 20;42(3):258-265. doi: 10.1200/JCO.22.02636. Epub 2023 Oct 4. J Clin Oncol. 2024. PMID: 37793085 Free PMC article.
Stability of hybrid versus vaccine immunity against BA.5 infection over 8 months.
Malato J, Ribeiro RM, Fernandes E, Leite PP, Casaca P, Antunes C, Fonseca VR, Gomes MC, Graca L. Malato J, et al. Lancet Infect Dis. 2023 Feb;23(2):148-150. doi: 10.1016/S1473-3099(22)00833-7. Epub 2023 Jan 5. Lancet Infect Dis. 2023. PMID: 36620968 Free PMC article. No abstract available.
Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma.
Huang HH, Ferguson ID, Thornton AM, Bastola P, Lam C, Lin YT, Choudhry P, Mariano MC, Marcoulis MD, Teo CF, Malato J, Phojanakong PJ, Martin TG 3rd, Wolf JL, Wong SW, Shah N, Hann B, Brooks AN, Wiita AP. Huang HH, et al. Among authors: malato j. Nat Commun. 2020 Apr 22;11(1):1931. doi: 10.1038/s41467-020-15521-4. Nat Commun. 2020. PMID: 32321912 Free PMC article.
Revisiting IgG Antibody Reactivity to Epstein-Barr Virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Its Potential Application to Disease Diagnosis.
Sepúlveda N, Malato J, Sotzny F, Grabowska AD, Fonseca A, Cordeiro C, Graça L, Biecek P, Behrends U, Mautner J, Westermeier F, Lacerda EM, Scheibenbogen C. Sepúlveda N, et al. Among authors: malato j. Front Med (Lausanne). 2022 Jun 24;9:921101. doi: 10.3389/fmed.2022.921101. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35814774 Free PMC article.
15 results